Adverum Biotechnologies Stock Price

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adverum Biotechnologies Inc ADVM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 12.18 07:00:32
Close Price Low Price High Price Open Price Previous Close
Bid Price Ask Price Spread News
11.77 12.87 1.10 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 12.18 USD

Adverum Biotechnologies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.19B 97.33M 89.69M $ 250.00k $ - -1.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Adverum Biotechnologies News

Date Time Source News Article
10/20/202009:00GlobeNewswire Inc.Adverum Biotechnologies to Present New Data from the OPTIC..
9/15/202008:00GlobeNewswire Inc.Adverum Biotechnologies Announces Appointment of Christopher..
9/10/202008:00GlobeNewswire Inc.Adverum Biotechnologies to Participate in the Cantor Virtual..
8/20/202014:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
8/19/202018:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/19/202018:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/18/202009:00GlobeNewswire Inc.Adverum Biotechnologies Announces Closing of $217..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADVM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week11.7012.5811.2812.07660,0990.484.1%
1 Month10.4412.589.8311.29801,0171.7416.67%
3 Months17.9119.35999.8312.421,154,620-5.73-31.99%
6 Months13.3926.989.8316.461,202,340-1.21-9.04%
1 Year7.4526.986.5813.761,243,0354.7363.49%
3 Years3.1526.982.629.791,011,8319.03286.67%
5 Years8.0026.982.408.99712,0424.1852.25%

Adverum Biotechnologies Description

Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.
Your Recent History
Adverum Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201028 12:58:48